A novel combination treatment of chlorhexidine gluconate, natamycin (Pimaricin) and debridement for a Acanthamoeba keratitis [1]

Japanese Journal of Ophthalmology

Volumn 47, Issue 6, 2003, Pages 616-617

  Kitagawa, Kazuko ^a   Nakamura, Takako ^a   Takahashi, Nobuo ^a   Oikawa, Yosaburo ^a   Ikeda, Teruaki ^a  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

Author keywords

Acanthamoeba keratitis; Chlorhexidine gluconate; Natamycin

Indexed keywords

ACICLOVIR; CHLORHEXIDINE GLUCONATE; FLUCONAZOLE; ITRACONAZOLE; NATAMYCIN;

ACANTHAMOEBA; ADULT; CASE REPORT; CLINICAL FEATURE; DEBRIDEMENT; DISEASE COURSE; FEMALE; HUMAN; KERATITIS; KERATOPLASTY; LETTER; PRIORITY JOURNAL; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 0242551306     PISSN: 00215155     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jjo.2003.08.005     Document Type: Article

References (5)

1. Hay J., Kirkness C.M., Seal D.V., Wright P. Drug resistance and Acanthamoeba keratitis: the quest for alternative antiprotozoal chemotherapy. Eye. 8:(Pt 5):1994;555-563.
2. O'Day D.M., Head W.S. Advances in the management of keratomycosis and Acanthamoeba keratitis. Cornea. 19:2000;681-687.
3. Ishibashi Y., Matsumoto Y., Kabata T., et al. Oral itraconazole and topical miconazole with debridement for Acanthamoeba keratitis. Am J Ophthalmol. 109:1990;121-126.
4. Inoue T., Asari S., Tahara K., Hayashi K., Kiritoshi A., Shimomura Y. Acanthamoeba keratitis with symbiosis of Hartmannella ameba. Am J Ophthalmol. 125:1998;721-723.
5. Elder M.J., Kilvington S., Dart J.K. A clinicopathologic study of in vitro sensitivity testing and Acanthamoeba keratitis. Invest Ophthalmol Vis Sci. 35:1994;1059-1064.